In vitro Assessment of Environmental Compound-Induced Cardiotoxicity Potential Using Human Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes

被引：0
|
作者：
Sirenko, O. [1 ]
Kristen, R. R. [2 ]
Behl, M. [2 ,3 ]
Parham, F. [2 ]
Anson, B. [4 ]
Cromwell, E. F. [1 ]
Tice, R. R. [2 ]
机构：
[1] Mol Devices LLC, Sunnyvale, CA USA
[2] NIEHS, Div Natl Toxicol Program, NIH, Res Triangle Pk, NC USA
[3] Kelly Govt Solut, Res Triangle Pk, NC USA
[4] Cellular Dynam Int, Madison, WI USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1086
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Assessment of In Vitro Compound-Induced Pro-arrhythmia in Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cardiomyocytes Using Multiple Assay Platforms
    de Korte, Tessa
    Stevenhagen, Fleur
    Nacken, Peter
    den Hartogh, Sabine
    Wilbers, Rene
    Langenberg, Karin
    Dunska, Marta
    Braam, Stefan
    Vlaming, Maria
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 197 - 197
  • [2] An in vitro assessment of delayed HDAC inhibitor-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Kopljar, Ivan
    Vlaminckx, Eddy
    Lu, Hua Rong
    Gallacher, David
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 385 - 385
  • [3] Modeling Carfilzomib Induced Cardiotoxicity Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes
    Forghani, Parvin
    Rashid, Aysha
    Li, Dong
    Mandawat, Anant
    Xu, Chunhui
    CIRCULATION RESEARCH, 2020, 127
  • [4] In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model
    Sirenko, Oksana
    Grimm, Fabian A.
    Ryan, Kristen R.
    Iwata, Yasuhiro
    Chiu, Weihsueh A.
    Parham, Frederick
    Wignall, Jessica A.
    Anson, Blake
    Cromwell, Evan F.
    Behl, Mamta
    Rusyn, Ivan
    Tice, Raymond R.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 322 : 60 - 74
  • [5] Prediction of cardiotoxicity potential using targeted metabolomics and human induced pluripotent stem cell-derived cardiomyocytes
    Palmer, Jessica A.
    Smith, Alan
    Colwell, Michael
    Ludwig, Michael
    Gryshkova, Vitalina
    Valentin, Jean-Pierre
    Donley, Elizabeth
    Kirchner, Fred
    Burrier, Robert
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [6] Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes
    Watanabe, Hitoshi
    Honda, Yayoi
    Deguchi, Jiro
    Yamada, Toru
    Bando, Kiyoko
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2017, 42 (04): : 519 - 527
  • [7] Kinase inhibitor-induced cardiotoxicity assessed in vitro with human pluripotent stem cell derived cardiomyocytes
    Xian, Hai-Qing
    Blanco, Carmina
    Bonham, Kristina
    Snodgrass, H. Ralph
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 437
  • [8] High-throughput assessment of compound-induced proarrhythmic effects in human iPSC-derived cardiomyocytes
    Sirenko, Oksana
    Crittenden, Carole
    Lertkiatmongkol, Panida
    Guan, April
    Dresden, Borys
    Sridhar, Krithika
    Servant, Nicole
    Vargas-Hurlston, Sarah
    WeiDavid, Haiyang
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [9] Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
    Schwach, Verena
    Slaats, Rolf H.
    Passier, Robert
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [10] Multiparametric assessment of cardiotoxicity of chemotherapeutic drugs in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes
    Mulder, Petra
    Famili, Farbod
    de Korte, Tessa
    Hechard, Celine
    Braam, Stefan R.
    Vlaming, Maria L.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 150 - 151
12345